Lipid droplet biogenesis and COX-2 pathway activation are triggered by Barrett’s esophagus and adenocarcinoma, but not esophageal squamous cell carcinoma risk factors
Abstract Esophageal cancer (EC) is an aggressive disease, presenting two main histological subtypes: adenocarcinoma (EAC) and squamous cell carcinoma (ESCC). The two EC subtypes widely differ concerning virtually all factors. ESCC development is mainly associated with tobacco and alcohol abuse, wher...
Guardado en:
Autores principales: | N. Carrossini, N. Meireles Da Costa, E. Andrade-Barreto, V. P. L. Sousa, P. Nicolau-Neto, P. T. Souza-Santos, G. R. Mansur, L. Wernersbach, P. T. Bozza, J. P. B. Viola, Luis Felipe Ribeiro Pinto |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/425da1fa68414c7fbd4cac79e4f3ce71 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Genetic profiles of Barrett’s esophagus and esophageal adenocarcinoma in Japanese patients
por: Mamoru Tokunaga, et al.
Publicado: (2021) -
Whole genome expression array profiling highlights differences in mucosal defense genes in Barrett's esophagus and esophageal adenocarcinoma.
por: Derek J Nancarrow, et al.
Publicado: (2011) -
Identification of miRNAs and genes for predicting Barrett's esophagus progressing to esophageal adenocarcinoma using miRNA-mRNA integrated analysis.
por: Chengjiao Yao, et al.
Publicado: (2021) -
HOXA13 in etiology and oncogenic potential of Barrett’s esophagus
por: Vincent T. Janmaat, et al.
Publicado: (2021) -
Optimal management of Barrett's esophagus: pharmacologic, endoscopic, and surgical interventions
por: Konda VJA, et al.
Publicado: (2011)